Nabla Named to the 2025 New York Digital Health 100 by Digital Health New York (DHNY)

DH100 recognizes those companies that have helped make New York the capital of healthcare innovation

NEW YORK, Feb. 11, 2025 /PRNewswire/ -- Nabla, the leading ambient AI assistant for clinicians, is proud to announce its inclusion in the 2025 New York Digital Health 100 (DH100), a prestigious list recognizing the most innovative and impactful digital health startups in New York. Digital Health New York (DHNY) publishes the annual list in conjunction with the 2025 New York Healthcare Innovation Report, which analyzes the digital health sector's investment trends, challenges, and opportunities. 

Nabla has over 50,000 clinician users and an average of 36,000 encounters daily, making it one of the leading ambient AI assistants in the US. In 2024, Nabla landed 80 enterprise contracts, including those with the Children's Hospital of Los Angeles, the University of Iowa Health Care, Carle Health, Denver Health, and Catalight.

Nabla is a versatile, health-equity-focused ambient AI assistant that supports 35 languages and is integrated with multiple EHRs. Its ability to deliver a well-designed solution that meets users' needs with extensive customization options while also being intuitive and easy to use has contributed to its rapid adoption by providers nationwide. Unlike traditional health IT implementations, the organic growth that Nabla has managed to achieve in health systems underscores the value of creating technology that users embrace without the need for forced adoption.

"At Nabla, we're passionate about improving the lives of clinicians through technological innovations," said Alex LeBrun, co-founder and CEO of Nabla. "Being named as one of the New York Digital Health 100 is a testament to the tireless efforts of our entire team. We're privileged to be recognized among so many highly innovative companies in New York."

"Now in its sixth year, the New York DH100 has evolved and grown, and in that time, the digital health ecosystem in New York has also reached unprecedented levels of innovation and impact," said Bunny Ellerin, co-founder and CEO, DHNY. "We are honored to celebrate these organizations, whose dedication to transformation and progress is driving the future of healthcare.

Widely recognized by health systems for its unmatched commitment to data privacy and security, Nabla ensures the highest levels of confidentiality and compliance with privacy regulations. Recently, the company joined CHAI to address the urgent need for quality assurance, representation, and ethical standards in using AI in healthcare.

To download a copy of the New York Healthcare Innovation Report, please click here.

About Nabla
Nabla is the leading ambient AI assistant, reducing practitioner stress and improving patient care. Nabla produces AI-generated clinical notes in seconds from any encounter across all specialties. Powered by proprietary LLMs fine-tuned to the medical field, Nabla's capabilities include AI-enabled medical coding identification and smooth EHR integrations.

The company's leadership includes: Alex Lebrun (CEO), with over two decades of experience building AI products, and whose companies have been acquired by Nuance (VirtuOz) and Facebook (Wit.ai); Delphine Groll (COO) and Martin Raison (CTO). Ed Lee, MD, MPH, who was previously CIO at The Permanente Federation, recently joined Nabla as Chief Medical Officer. He heads Nabla's Clinical Advisory Board, formed by 20+ seasoned clinical leaders.

On the technological side, the company's advisors include Yann LeCun, VP & Chief AI Scientist at Meta, and Tony Fadell, inventor of the iPod and former Apple executive, among others.

Nabla has raised a total of $49M, its most recent fundraising being a $30M series B led by global venture capital firm Cathay Innovation. For more information, please visit: www.nabla.com.

About Digital Health New York (DHNY) 
Digital Health New York (DHNY) is a connected community of digital health leaders who share ideas, spark new directions and create success across the entire ecosystem. As an organization, we seek to increase the visibility of New York City as a leader in healthcare innovation and showcase the companies and leaders creating the future of healthcare. Our flagship event, DHNY Summit, brings together an elite group of entrepreneurs, investors, payers, providers and executives to cultivate the New York digital health community and drive impactful conversations around the current and future state of digital health. DHNY was founded in 2022 in collaboration with AlleyCorp. For more information or to join DHNY's mailing list, please visit www.dhny.co.

DH100 Methodology 
To compile the DH100, we invited companies to complete an in-depth application with both quantitative and qualitative measures to help us get to know the company better. We also used our dynamic database of digital health companies in the region to round out the consideration set. A company qualified for consideration if it maintained headquarters or employed at least 5 people in the New York region. Companies that were public or non-profit; founded before 2014; or had an exit were excluded. We evaluated companies on a number of factors, including but not limited to: strength of application, leadership, number of employees, funding, revenue, market fit, differentiated offerings, and community engagement.

Media Contact
[email protected]

SOURCE Nabla